Utah Admin. Code R156-37-604 - Prescribing of Controlled Substances for Weight Reduction or Control
(1) A practitioner may not prescribe,
dispense, or administer a Schedule II or Schedule III controlled substance for
weight reduction or control.
(2) A
prescribing practitioner may prescribe or administer a Schedule IV controlled
substance in treating excessive weight leading to increased health risks only
if the prescribing practitioner complies with each of the following conditions:
(a) medication is used only as an adjunct to
a comprehensive weight loss program based on supplemental weight loss
activities including changing lifestyle counseling, nutritional education, and
a regular, individualized exercise regimen;
(b) before initiating treatment the
prescribing practitioner:
(i) determines
through thorough review of past medical records that the patient has made a
substantial good-faith effort to lose weight in a comprehensive weight loss
program without the use of controlled substances, and the previous regimen has
not been effective;
(ii) obtains a
complete history, performs a complete physical examination of the patient, and
rules out the existence of recognized contraindications to the use of the
medication;
(iii) determines and
documents the assessment in the patient's medical record, that the health
benefit to the patient greatly outweighs the possible risks of the medications
prescribed; and
(iv) discusses with
the patient the possible risks associated with the medication, and has on
record an informed consent that clearly documents that the long term effects of
using controlled substances for weight loss or weight control are not
known;
(c) throughout the
prescribing period, the prescribing practitioner:
(i) supervises, oversees, and regularly
monitors the patient, including the patient's participation in supplemental
weight loss activities, efficacy of the medication, and advisability of
continuing to prescribe the weight loss or weight control medication;
and
(ii) maintains a central
medical record that contains at least the following information:
(A) the goal of treatment or target
weight;
(B) the ongoing progress
toward that goal or maintenance of the weight loss;
(C) the patient's supplemental weight loss
activities with documentation of compliance with the comprehensive weight loss
program; and
(d) the prescribing practitioner shall
immediately discontinue the weight loss medication if:
(i) the practitioner knows or should know
that the patient is pregnant;
(ii)
the patient has consumed or disposed of any controlled substance other than in
compliance with the prescribing practitioner's directions;
(iii) the patient is abusing the controlled
substance being prescribed for weight loss;
(iv) the patient develops a contraindication
of therapy;
(v) the medication is
not effective; or
(vi) the patient
is not complying with the agreed upon comprehensive weight loss
program.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.